BioLASCO Taiwan Statistics
Total Valuation
BioLASCO Taiwan has a market cap or net worth of TWD 718.42 million. The enterprise value is 675.30 million.
Important Dates
The next estimated earnings date is Monday, November 23, 2026.
| Earnings Date | Nov 23, 2026 |
| Ex-Dividend Date | Aug 7, 2026 |
Share Statistics
BioLASCO Taiwan has 25.61 million shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | 25.61M |
| Shares Outstanding | 25.61M |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 30.03% |
| Owned by Institutions (%) | n/a |
| Float | 15.85M |
Valuation Ratios
The trailing PE ratio is 16.12.
| PE Ratio | 16.12 |
| Forward PE | n/a |
| PS Ratio | 2.70 |
| PB Ratio | 1.65 |
| P/TBV Ratio | 1.65 |
| P/FCF Ratio | 18.39 |
| P/OCF Ratio | 15.60 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 10.39, with an EV/FCF ratio of 17.28.
| EV / Earnings | 15.12 |
| EV / Sales | 2.53 |
| EV / EBITDA | 10.39 |
| EV / EBIT | 13.11 |
| EV / FCF | 17.28 |
Financial Position
The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.16.
| Current Ratio | 3.47 |
| Quick Ratio | 2.79 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 1.16 |
| Debt / FCF | 1.83 |
| Interest Coverage | 22.95 |
Financial Efficiency
Return on equity (ROE) is 10.16% and return on invested capital (ROIC) is 10.82%.
| Return on Equity (ROE) | 10.16% |
| Return on Assets (ROA) | 5.28% |
| Return on Invested Capital (ROIC) | 10.82% |
| Return on Capital Employed (ROCE) | 9.57% |
| Weighted Average Cost of Capital (WACC) | 4.87% |
| Revenue Per Employee | 2.93M |
| Profits Per Employee | 490,670 |
| Employee Count | 91 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 5.39 |
Taxes
In the past 12 months, BioLASCO Taiwan has paid 7.72 million in taxes.
| Income Tax | 7.72M |
| Effective Tax Rate | 14.73% |
Stock Price Statistics
The stock price has decreased by -10.53% in the last 52 weeks. The beta is 0.16, so BioLASCO Taiwan's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -10.53% |
| 50-Day Moving Average | 28.51 |
| 200-Day Moving Average | 29.51 |
| Relative Strength Index (RSI) | 48.61 |
| Average Volume (20 Days) | 5,372 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioLASCO Taiwan had revenue of TWD 266.56 million and earned 44.65 million in profits. Earnings per share was 1.74.
| Revenue | 266.56M |
| Gross Profit | 105.47M |
| Operating Income | 48.56M |
| Pretax Income | 52.37M |
| Net Income | 44.65M |
| EBITDA | 62.03M |
| EBIT | 48.56M |
| Earnings Per Share (EPS) | 1.74 |
Full Income Statement Balance Sheet
The company has 114.78 million in cash and 71.66 million in debt, with a net cash position of 43.12 million or 1.68 per share.
| Cash & Cash Equivalents | 114.78M |
| Total Debt | 71.66M |
| Net Cash | 43.12M |
| Net Cash Per Share | 1.68 |
| Equity (Book Value) | 435.66M |
| Book Value Per Share | 16.88 |
| Working Capital | 140.44M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 46.05 million and capital expenditures -6.97 million, giving a free cash flow of 39.07 million.
| Operating Cash Flow | 46.05M |
| Capital Expenditures | -6.97M |
| Depreciation & Amortization | 13.47M |
| Net Borrowing | -16.90M |
| Free Cash Flow | 39.07M |
| FCF Per Share | 1.53 |
Full Cash Flow Statement Margins
Gross margin is 39.57%, with operating and profit margins of 18.22% and 16.75%.
| Gross Margin | 39.57% |
| Operating Margin | 18.22% |
| Pretax Margin | 19.65% |
| Profit Margin | 16.75% |
| EBITDA Margin | 23.27% |
| EBIT Margin | 18.22% |
| FCF Margin | 14.66% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 5.35%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 5.35% |
| Dividend Growth (YoY) | 3.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 88.91% |
| FCF Payout Ratio | 101.60% |
| Buyback Yield | 0.06% |
| Shareholder Yield | 5.41% |
| Earnings Yield | 6.21% |
| FCF Yield | 5.44% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
The last stock split was on July 30, 2018. It was a forward split with a ratio of 1.055.
| Last Split Date | Jul 30, 2018 |
| Split Type | Forward |
| Split Ratio | 1.055 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |